-
Mashup Score: 0
I participated in “Modern Treatment Approaches to Prostate Cancer,” a CME/MOC activity from @PeerView
Source: api.learn2.peerview.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 2SUO 2021: Mitigating Infection Rates in Prostate Biopsy - 2 year(s) ago
SUO 2021 transperineal prostate biopsy, strategies to mitigate infections among patients undergoing prostate biopsy, transrectal ultrasound guided (TRUS) prostate biopsy, role of transperineal biopsy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Mitigating infection rates in prostate biopsy. Presentation by @EdwardSchaeffer @NM_Urology. #SUO21 written coverage by @WallisCJD @UofT on UroToday > https://t.co/4wiaaKdyVx @UroOnc @NUFeinbergMed https://t.co/XnE1rjYyTq
-
-
Mashup Score: 3SUO 2021: Integrating Transperineal Prostate Biopsy Into the Clinic: Logistical Considerations for Practice - 2 year(s) ago
SUO 2021 transperineal prostate biopsy in the clinic, diagnostic prostate biopsy are to detect clinically significant disease, transrectal biopsy, benefits and drawbacks to a transperineal approach, TRUS probe, MRI-US fusion.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Integrating transperineal #Prostate biopsy into the clinic: logistical considerations for practice. Presentation by @ashleyrossmdphd @NM_Urology. #SUO21 written coverage by @WallisCJD @UofT on UroToday > https://t.co/7VNTriUwUZ @UroOnc https://t.co/p5sbBfXVom
-
-
Mashup Score: 2SUO 2021: Should Transperineal Biopsy Be Standard of Care? - 2 year(s) ago
SUO 2021 Should Transperineal Biopsy Be Standard of Care? transperineal prostate biopsy, TRUS biopsy, high-quality TRUS guided prostate biopsy, complications associated with TRUS biopsy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Should transperineal biopsy be Standard of Care? Presentation by Deborah Kaye, MD, MS @DukeCancer. #SUO21 written coverage by @WallisCJD @UofT > https://t.co/E9ckkWxRwF @UroOnc https://t.co/JcScyLPNXS
-
-
Mashup Score: 0SUO 2021: Smarter Screening - Integrating Emerging Polygenic Risk Scores and PSA Screening - 2 year(s) ago
SUO 2021 early prostate cancer diagnosis and treatment, role of polygenic risk scores (PRS) to improve prostate specific antigen (PSA)-based prostate cancer screening, health disparities in the United States.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Smarter screening - Integrating emerging polygenic risk scores and PSA screening. Presentation by @BurcuDarst @KeckMedUSC. #SUO21 written coverage by @WallisCJD @UofT > https://t.co/MxzAxMQtWN @UroOnc https://t.co/Ybo3I1fP5z
-
-
Mashup Score: 0SUO 2021: Should Transperineal Biopsy Be Standard of Care for Patients Undergoing Prostate Biopsy? - 2 year(s) ago
SUO 2021 Should Transperineal Be Standard of Care for Patients Undergoing Prostate Biopsy? transrectal ultrasound biopsy (TRUS) as the standard of care, transrectal biopsy, EAU guidelines suggest transperineal biopsy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Should transperineal biopsy be standard of care for patients undergoing prostate biopsy? Presentation by @jeshoag @caseccc. #SUO21 written coverage by @WallisCJD @UofT on UroToday > https://t.co/WXxjZ508pS @UHhospitals @UroOnc https://t.co/WJqaB9l1BL
-
-
Mashup Score: 1SUO 2021: Adverse Prostate Cancer Pathological Variants: Considerations for Management - 2 year(s) ago
Society of Urologic Oncology Annual Meeting, pathological variants of prostate cancer and their influence on treatment, germline mutations in DNA repair genes, underdiagnosis on prostate biopsy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Adverse #ProstateCancer pathological variants: considerations for management. Presentation by @JGordetsky @VUMCPathology. #SUO21 written coverage by @WallisCJD @UofT on UroToday > https://t.co/fS9pr99U05 @UroOnc https://t.co/xDFYGO0E16
-
-
Mashup Score: 0SUO 2021: Our Specialty, Our Society and Our Patients -- Moving Beyond Ambition to Organizational Competency from a US Health System Perspective - 2 year(s) ago
SUO 2021 renal masses, Society of Urologic Oncology Annual Meeting, United States Health System, difference between equitable and equal care, COVID-19 pandemic, Minorities in the Health Professions, African American physicians, therapy for prostate cancer.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Our specialty, our society, and our patients -- Moving beyond ambition to organizational competency from a US health system perspective. Presentation by @TMDownsmd @UVA. #SUO21 written coverage by @WallisCJD @UofT on UroToday > https://t.co/hoghYe9vyB @UroOnc https://t.co/btBjE3LKqO
-
-
Mashup Score: 2Enhancing the negative predictive value of cystoscopy - 2 year(s) ago
At the 2021 Society of Urologic Oncology Annual Meeting, Alexander Kutikov, MD, FACS, gave a presentation on determining and helping improve the negative predictive value of cystoscopy in ruling out muscle invasive bladder cancer.
Source: Urology TimesCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Bladder removal is considered the gold standard of treating #bladdercancer but it can be difficult to predict who isn't harboring cancer in their bladder, explains Fox Chase's Alexander Kutikov, MD, FACS, (@uretericbud). Read about his #SUO21 presentation:https://t.co/yYkmLJcXVU https://t.co/5H1M2XGbRH
-
-
Mashup Score: 0Trial investigates negative predictive value of cystoscopic examinations in patients with bladder cancer - 2 year(s) ago
“The problem is that we are not very good at predicting who is not harboring any cancer in their bladder,” says Alexander Kutikov, MD, FACS.
Source: Urology TimesCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Fox Chase's Dr. Alexander Kutikov (@uretericbud), chief of the Division of Urology and Urologic Oncology shares insight into his recent presentation at #SUO21. He discusses bladder removal, #bladdercancer biomarkers, treatment, and more. Watch here: https://t.co/sEeQRezFz9
-
RT @SpeakJen: See a new #prostatecancer activity via @PeerView @PBarataMD #SUO21 #ProstateCancer #CME #MOC https://t.co/jl3RrUbcet